Search
for

    Sort by

    Research 31–60 of 1000+

    1. Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia Frontiers in Pharmacology · 2020 · 35 citations
    2. Androgen Receptor Gene Polymorphism and Prostate Zonal Volumes in Australian and Chinese Men Journal of Andrology · 2000 · 34 citations
    3. Patients with a large prostate show a higher prevalence of androgenetic alopecia Archives of Dermatological Research · 2004 · 33 citations
    4. Finasteride-its impact on sexual function and prostate cancer Journal of Cutaneous and Aesthetic Surgery · 2009 · 33 citations
    5. Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study BJUI · 2015 · 31 citations
    6. Prevention and treatment of experimental prostate cancer in lobund-wistar rats. I. Effects of estradiol, dihydrotestosterone, and castration 1989 · 31 citations
    7. Characteristics of flutamide action on prostatic and testicular functions in the rat Journal of Steroid Biochemistry · 1988 · 30 citations
    8. Differential expression of steroid 5α-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer Endocrine Related Cancer · 2010 · 30 citations
    9. Baldness, benign prostate hyperplasia, prostate cancer and androgen levels The Aging Male · 2008 · 30 citations
    10. Male pattern baldness and prostate cancer risk in a population-based case–control study Cancer epidemiology · 2010 · 29 citations
    11. Androgenetic alopecia as an early marker of benign prostatic hyperplasia Journal of The American Academy of Dermatology · 2011 · 28 citations
    12. Androgenic alopecia is not useful as an indicator of men at high risk of prostate cancer European Journal of Cancer · 2010 · 28 citations
    13. Hormonal prevention of prostate cancer Urologic oncology · 2003 · 28 citations
    14. Risks and side effects in the medical management of benign prostatic hyperplasia Prostate International · 2023 · 26 citations
    15. Dutasteride for the treatment of benign prostatic hyperplasia Expert opinion on pharmacotherapy · 2013 · 24 citations
    16. Ganoderma lucidum is an inhibitor of testosterone-induced prostatic hyperplasia in rats Andrologia · 2011 · 24 citations
    17. Benign Prostatic Hyperplasia: A Disorder of Androgen Metabolism in the Male Journal of the American Geriatrics Society · 1984 · 23 citations
    18. Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review Prostate Cancer and Prostatic Diseases · 2021 · 21 citations
    19. Relationship of Early-Onset Baldness to Prostate Cancer in African-American Men Cancer Epidemiology, Biomarkers & Prevention · 2013 · 21 citations
    20. Comparative Study of Therapeutic Effect of Dibenyline, Finasteride, and Combination Drugs for Symptomatic Benign Prostatic Hyperplasia Urologia internationalis · 1998 · 21 citations
    21. Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer Cancers · 2021 · 20 citations
    22. The prostaglandin synthases, COX-2 and L-PGDS, mediate prostate hyperplasia induced by low-dose bisphenol A Scientific Reports · 2020 · 20 citations
    23. Corn silk extract improves benign prostatic hyperplasia in experimental rat model Nutrition Research and Practice · 2017 · 20 citations
    24. Ezetimibe Reduces Enlarged Prostate in an Animal Model of Benign Prostatic Hyperplasia The Journal of Urology · 2010 · 20 citations
    25. Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis PLOS ONE · 2018 · 19 citations
    26. Benign prostatic hyperplasia and male lower urinary symptoms: A guide for family physicians Asian journal of urology · 2017 · 19 citations
    27. Cardiovascular effects of hormone therapy for prostate cancer Drug Healthcare and Patient Safety · 2015 · 18 citations
    28. Apocrine sweat gland obstruction by antiperspirants allowing transdermal absorption of cutaneous generated hormones and pheromones as a link to the observed incidence rates of breast and prostate cancer in the 20th century Medical Hypotheses · 2009 · 18 citations
    29. The Relationship Between Metformin and Serum Prostate‐Specific Antigen Levels The Prostate · 2016 · 17 citations
    30. Male Pattern Baldness in Relation to Prostate Cancer–Specific Mortality: A Prospective Analysis in the NHANES I Epidemiologic Follow-up Study American Journal of Epidemiology · 2016 · 17 citations